相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Phase I trial of everolimus in combination with thoracic radiotherapy in non-small-cell lung cancer
E. Deutsch et al.
ANNALS OF ONCOLOGY (2015)
Phase 2 trial of erlotinib combined with cisplatin and radiotherapy in patients with locally advanced cervical cancer
Angelica Nogueira-Rodrigues et al.
CANCER (2014)
Comparison of adenocarcinoma (ACA) and squamous cell carcinoma (SCC) of the uterine cervix in a sub-optimally screened cohort: A population-based epidemiologic study of 51,842 women in Brazil
Angelica Nogueira-Rodrigues et al.
GYNECOLOGIC ONCOLOGY (2014)
mTOR inhibitors and their clinical application in cervical, endometrial and ovarian cancers: A critical review
Nader Husseinzadeh et al.
GYNECOLOGIC ONCOLOGY (2014)
Advanced gynecologic malignancies treated with a combination of the VEGF inhibitor bevacizumab and the mTOR inhibitor temsirolimus
Sarina A. Piha-Paul et al.
ONCOTARGET (2014)
Phase II study of temsirolimus (CCI-779) in women with recurrent, unresectable, locally advanced or metastatic carcinoma of the cervix. A trial of the NCIC Clinical Trials Group (NCIC CTG IND 199)
A. V. Tinker et al.
GYNECOLOGIC ONCOLOGY (2013)
A Phase 1 Study of Everolimus plus Weekly Cisplatin plus Intensity Modulated Radiation Therapy in Head-and-Neck Cancer
Matthew G. Fury et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2013)
RTOG 0913: A Phase 1 Study of Daily Everolimus (RAD001) in Combination With Radiation Therapy and Temozolomide in Patients With Newly Diagnosed Glioblastoma
Prakash Chinnaiyan et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2013)
A phase I study of daily everolimus plus low-dose weekly cisplatin for patients with advanced solid tumors
Matthew G. Fury et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2012)
Everolimus in Postmenopausal Hormone-Receptor-Positive Advanced Breast Cancer
Jose Baselga et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
A Phase I Trial of Liposomal Doxorubicin, Bevacizumab, and Temsirolimus in Patients with Advanced Gynecologic and Breast Malignancies
John W. Moroney et al.
CLINICAL CANCER RESEARCH (2011)
NORTH CENTRAL CANCER TREATMENT GROUP PHASE I TRIAL N057K OF EVEROLIMUS (RAD001) AND TEMOZOLOMIDE IN COMBINATION WITH RADIATION THERAPY IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME
Jann N. Sarkaria et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2011)
Everolimus for Advanced Pancreatic Neuroendocrine Tumors.
James C. Yao et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Phase 3 Trial of Everolimus for Metastatic Renal Cell Carcinoma Final Results and Analysis of Prognostic Factors
Robert J. Motzer et al.
CANCER (2010)
Combination of cetuximab with chemoradiation, trastuzumab or MAPK inhibitors: mechanisms of sensitisation of cervical cancer cells
D. D. Meira et al.
BRITISH JOURNAL OF CANCER (2009)
Different antiproliferative effects of matuzumab and cetuximab in A431 cells are associated with persistent activity of the MAPK pathway
Debora Dummer Meira et al.
EUROPEAN JOURNAL OF CANCER (2009)
Targeting the mTOR Signaling Network for Cancer Therapy
Funda Meric-Bernstam et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Phase I Trial of Erlotinib Combined with Cisplatin and Radiotherapy for Patients with Locally Advanced Cervical Squamous Cell Cancer
Angelica Nogueira-Rodrigues et al.
CLINICAL CANCER RESEARCH (2008)
Concomitant and neoadjuvant chemotherapy for cervical cancer
J. F. Tierney et al.
CLINICAL ONCOLOGY (2008)
Phase I pharmacokinetic and pharmacodynamic study of the oral mammalian target of rapamycin inhibitor everolimus in patients with advanced solid tumors
Anne O'Donnell et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Surgery after concurrent chemoradiotherapy and brachytherapy for the treatment of advanced cervical cancer: Morbidity and outcome: Results of a multicenter study of the GCCLCC (Groupe des Chirurgiens de Centre de Lutte Contre le Cancer)
J. M. Classe et al.
GYNECOLOGIC ONCOLOGY (2006)
Deregulation of eIF4E: 4E-BP1 in differentiated human papillomavirus-containing cells leads to high levels of expression of the E7 oncoprotein
Kwang-Jin Oh et al.
JOURNAL OF VIROLOGY (2006)
Molecular analysis of the PI3K-AKT pathway in uterine cervical neoplasia:: Frequent PIK3CA amplification and AKT phosphorylation
BI Bertelsen et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
The mTOR inhibitor RAD001 sensitizes tumor cells to DNA-damaged induced apoptosis through inhibition of p21 translation
I Beuvink et al.
CELL (2005)
The causal relation between human papillomavirus and cervical cancer
FX Bosch et al.
JOURNAL OF CLINICAL PATHOLOGY (2002)
Phase III trial comparing radical radiotherapy with and without cisplatin chemotherapy in patients with advanced squamous cell cancer of the cervix
R Pearcey et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
High-throughput semi-automated 96-well liquid/liquid extraction and liquid chromatography/mass spectrometric analysis of everolimus (RAD 001) and cyclosporin a (CsA) in whole blood
N Brignol et al.
RAPID COMMUNICATIONS IN MASS SPECTROMETRY (2001)
Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix
WA Peters et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
分享论文
